清营汤结合西医常规疗法治疗脓毒症临床观察  被引量:15

Clinical Observation of “Qingying Decoction”Combined with Western Medicine in Treating Patients with Sepsis

在线阅读下载全文

作  者:计高荣[1] 何淼[1] 张卓成[1] 李黎[1] 

机构地区:[1]上海中医药大学附属曙光医院急诊科,上海200021

出  处:《上海中医药大学学报》2015年第4期27-29,共3页Academic Journal of Shanghai University of Traditional Chinese Medicine

摘  要:目的:探讨清营汤结合西医常规疗法治疗脓毒症的临床疗效。方法:纳入80例脓毒症患者,随机分为对照组40例和治疗组40例。两组患者均采用西医常规疗法治疗,治疗组患者在此基础上加服清营汤治疗,治疗周期为14 d。评价两组患者的临床疗效,比较治疗前后两组患者的血清炎性因子水平的变化。结果:治疗后,治疗组的临床总有效率为92.5%,对照组为72.5%,治疗组的疗效优于对照组(P<0.05)。治疗后,两组患者的血清C-反应蛋白(CRP)、肿瘤坏死因子-α(TNF-α)、白介素-8(IL-8)水平较治疗前均显著降低(P<0.05),且治疗组患者的血清CRP、TNF-α、IL-8水平低于对照组(P<0.05)。结论:清营汤结合西医常规疗法治疗脓毒症疗效较佳,值得在临床中推广、应用。Objective: To investigate the clinical effects of "Qingying Decoction" combined with western medicine in treating patients with sepsis. Methods: Eighty patients with sepsis were selected and randomly divided into control group and treatment group with 40 cases in each group. All the patients were treated with routine western medicine and the patients in the treatment group were treated with " Qingying Decoction" additionally with a course of 14 days. The clinical effect was evaluated, and the levels of serum inflammatory factors were detected. Results: After treatment, the total effective rates of treatment group and control group were 92.5% and 72.5% respectively, and the effect of treatment group was better than that of the control group ( P 〈 0.05 ). After treatment, the levels of serum CRP, TNF-ct and IL- 8 were significantly decreased in both groups (P 〈0.05 ), and the levels of serum CRP, TNF-α and IL-8 in the treatment group were lower than those of the control group ( P 〈 0.05 ). Conclusion : The clinical effect of " Qingying Decoction" combined with western medicine in treating patients with sepsis is effective and worthy of clinical promotion.

关 键 词:脓毒症 清营汤 中医药疗法 

分 类 号:R459.7[医药卫生—急诊医学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象